This antibody was produced by infecting a BALB/c mouse intranasally with WR.K1L-C7L-, a highly attentuated vaccinia virus. The mouse was subsequently challenged with intranasal inoculation of of wild type VACV, followed by intravenous injection with UV-inactivated VACV.